Gauthami Pulivendala | Translational Research | Young Researcher Award

Published on by Health Scientists

Dr. Gauthami Pulivendala | Translational Research | Young Researcher Award

Postdoc Associate | University of Miami | United States

Dr. Gauthami Pulivendala is a researcher at Sylvester Comprehensive Cancer Center, specializing in cancer biology, fibrosis, and molecular signaling pathways. Her work focuses on understanding mechanisms such as the ChREBPα-mediated regulation of hepatic stellate cell activation and its role in liver fibrosis, contributing to advancements in translational oncology. With 11 publications, 318 citations, and an h-index of 9, she demonstrates strong research impact and scientific productivity. Collaborating with an extensive network of co-authors, her research reflects interdisciplinary engagement across cancer biology and metabolic disease domains. Her contributions hold significant societal value by advancing knowledge in fibrosis and tumor microenvironment interactions, supporting the development of targeted therapies, and improving clinical strategies for cancer and liver-related diseases, thereby contributing to global health innovation and patient care outcomes.

Citation Metrics (Scopus)

318
240
160
80
0

Citations

318

Documents

11

h-index

9

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications


Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases

– Drug Delivery and Translational Research, 2020 | Citations: 62

Hui Saan Tham | Translational Research | Research Excellence Award

Published on by Health Scientists

Dr. Hui Saan Tham | Translational Research | Research Excellence Award

Director | Han Neuro Acupuncture & Herbal Specialist | Malaysia

Dr. Hui Saan Tham is the Chief Physician at Han Neuro Acupuncture and Herbal Specialists, specializing in translational research that integrates acupuncture, herbal medicine, and advanced medical technologies. Their recent publication on an EfficientNet-based deep learning system for ultrasound assessment of neck disorders reflects a pioneering approach to combining artificial intelligence with clinical diagnostics. Working collaboratively with multidisciplinary teams, they contribute to the development of innovative, evidence-based healthcare solutions. Although at an emerging stage in terms of publication count and citation metrics, their work demonstrates strong potential for impact in integrative and precision medicine. Their contributions hold significant societal value by promoting accessible, non-invasive therapeutic strategies and enhancing diagnostic accuracy, particularly in neuromuscular conditions, thereby supporting improved patient outcomes and advancing global healthcare innovation.

View Google Scholar Profile

Featured Publication

Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award

Published on by Health Scientists

Prof. Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award 

Former Vice Chancellor | Utkal University | India

Prof. (Dr.) Pradeep Kumar Chand is a distinguished academician and researcher, currently serving as Chairperson of NAAC Peer Teams constituted by the National Assessment and Accreditation Council (Government of India) and formerly the Vice Chancellor of a State University. He earned his B.Sc. (Botany Hons.) and M.Sc. (Botany) with top distinctions and obtained his Ph.D. in Science from a reputed university in the United Kingdom, specializing in Plant Biotechnology and Genetic Engineering. With over 37 years of teaching and research experience, Prof. Chand’s pioneering contributions encompass plant tissue culture, genetic transformation, somatic hybridization, DNA fingerprinting, biogenic nanotechnology, and phytochemical analysis. He has guided numerous postgraduate research scholars, including several Ph.D. and M.Phil. awardees, and has authored numerous research papers in reputed international and national journals. His work in green nanotechnology and nano-onco-therapeutics has earned wide academic recognition. Prof. Chand has been honored with prestigious fellowships from organizations such as the DBT, DST, and INSA, and has served as a Biotechnology Overseas Associate under the Government of India’s Department of Biotechnology. His research collaborations with globally recognized institutions in Europe, Asia, and the United States highlight his international scientific engagement. Additionally, Prof. Chand has held editorial and peer-review roles in several scientific journals, contributing significantly to advancing research standards in biotechnology and plant sciences both nationally and internationally. He has 2333 citations from 81 documents with an h-index of 27.

Profiles: Google Scholar | Scopus

Featured Publications

1. Genetically transformed root extracts of medicinal plant Sida acuta Burm.f. attenuate hyperglycemic effects in induced diabetic rats. (2025). Plant Cell, Tissue and Organ Culture.

2. Validation of PCR amplicon-based directed amplified minisatellite DNA (DAMD) markers for analysis of population structure and fruit trait association of promising Indian mangoes. (2025). Genetic Resources and Crop Evolution.

3. Hexavalent chromium bioaccumulation mediated enhancement of pyrethrin production in African marigold (Tagetes erecta L.): a promising plant for phytoremediation. (2023). Acta Physiologiae Plantarum.

4. Silver nanocrystals bio-fabricated using Rhizobium rhizogenes-transformed in vitro root extracts demonstrate health proactive properties. (2022). Bionanoscience.

5. Anthropogenic interventions regulate forest structure and carbon stock in transitional dry forests of Similipal Biosphere Reserve, India. (2022). Ecoscience.

Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Published on by Health Scientists

Dr. Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Research group leader | FIDIS/IDIS | Spain

Dr. Miguel García González is a distinguished biomedical researcher and Group Leader at the Instituto de Investigación Sanitaria de Santiago (IDIS/CHUS) in Spain, specializing in Molecular Genetics and Developmental Biology of Kidney Diseases. He earned his Ph.D. in Molecular Biology from the University of Santiago de Compostela, where he developed a strong foundation in genetics, molecular mechanisms, and translational nephrology. His research focuses on understanding the genetic and molecular bases of polycystic kidney disease (PKD) and related hereditary disorders, integrating genomic, cellular, and developmental biology approaches to identify novel therapeutic targets. Dr. García González has authored more than 40 peer-reviewed publications in high-impact journals such as Nature Medicine, PNAS, Kidney International, and Human Molecular Genetics, contributing significantly to the field’s understanding of renal pathophysiology. His work has received numerous national and international research grants and awards, recognizing his excellence in scientific innovation and mentorship. He actively participates in editorial and peer-review roles for several leading journals in nephrology and molecular biology, further influencing the direction of biomedical research. In addition to his research contributions, Dr. García González is deeply committed to training young scientists, supervising doctoral and postdoctoral researchers, and fostering interdisciplinary collaboration across clinical and molecular domains. His pioneering work continues to advance precision medicine approaches in nephrology, bridging basic science discoveries with clinical applications aimed at improving outcomes for patients with genetic kidney diseases. He has 1913 citations from 50 documents with an h-index of 20.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways. (2025). Cell Communication and Signaling.

2. Therapeutic opportunities in polycystic kidney and liver disease through extracellular matrix dynamics. (2025). Biochemical Pharmacology.

3. Characterization of recurrent UMOD variants (p.C255Y and p.Q316P) in a Galician cohort: Genotype–phenotype correlation and clinical implications. (2025). Nefrología.

4. Characterization of the functional component in human milk and identification of the molecular mechanisms undergoing prematurity. (2025). Clinical Nutrition.

5. HNF1B transcription factor: Key regulator in renal physiology and pathogenesis. (2025).